Shares of BioScrip (BIOS) gain 7% after BB&T initiates with a Buy rating and an elevated...

|By:, SA News Editor

Shares of BioScrip (BIOS) gain 7% after BB&T initiates with a Buy rating and an elevated price target of $10 - repping 61% upside potential for shares of the pharmacy and home health provider.